scholarly journals Attributable causes of breast cancer and ovarian cancer in China: Reproductive factors, oral contraceptives and hormone replacement therapy

2012 ◽  
Vol 24 (1) ◽  
pp. 9-17 ◽  
Author(s):  
Li Li ◽  
Jia Ji ◽  
Jian-bing Wang ◽  
Mayineur Niyazi ◽  
You-lin Qiao ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Ovarian Cancer ◽  
Hormone Replacement Therapy ◽  
Replacement Therapy ◽  
Oral Contraceptives ◽  
Hormone Replacement ◽  
Reproductive Factors

scholarly journals Hormone replacement therapy and breast cancer in former users of oral contraceptives—The Norwegian Women and Cancer study

2007 ◽  
Vol 121 (3) ◽  
pp. 645-648 ◽  
Author(s):  
Eiliv Lund ◽  
Kjersti Bakken ◽  
Vanessa Dumeaux ◽  
Vegard Andersen ◽  
Merethe Kumle
Keyword(s):  
Breast Cancer ◽  
Hormone Replacement Therapy ◽  
Replacement Therapy ◽  
Oral Contraceptives ◽  
Hormone Replacement ◽  
Cancer Study

Hormone Replacement Therapy in the Gynecologic and Breast Cancer Patient

1996 ◽  
Vol 3 (2) ◽  
pp. 101-106 ◽  
Author(s):  
Philip J. Disaia
Keyword(s):  
Breast Cancer ◽  
Ovarian Cancer ◽  
Heart Disease ◽  
Hormone Replacement Therapy ◽  
Cancer Patient ◽  
Ischemic Heart Disease ◽  
Replacement Therapy ◽  
Negative Impact ◽  
Hormone Replacement ◽  
Previous Diagnosis

Hormone replacement therapy has increased in use as a result of its well-established benefits as an effective tool against such consequences as osteoporosis and ischemic heart disease and in the management of menopausal symptoms. However, its possible negative impact on the survival of patients with a previous diagnosis of breast, uterine, or ovarian cancer remains controversial. The risk:benefit analysis of hormone replacement therapy in this setting warrants further investigation. In the meantime, patients should be counseled on the risks, benefits, and contraindications of hormone replacement therapy before embarking on its use.

Oral contraceptives, hormone replacement therapy and breast cancer risk: A cohort study of 16 928 women 48 years and older

2014 ◽  
Vol 53 (6) ◽  
pp. 752-758 ◽  
Author(s):  
Thuridur Thorbjarnardottir ◽  
Elinborg J. Olafsdottir ◽  
Unnur A. Valdimarsdottir ◽  
Orn Olafsson ◽  
Laufey Tryggvadottir
Keyword(s):  
Breast Cancer ◽  
Cohort Study ◽  
Hormone Replacement Therapy ◽  
Breast Cancer Risk ◽  
Cancer Risk ◽  
Replacement Therapy ◽  
Oral Contraceptives ◽  
Hormone Replacement
Sign in / Sign up

Export Citation Format

Share Document